06/23/2025
5:48 PM | Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
5:51 PM | Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Moran Susan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
5:32 PM | Fairmount Funds Management LLC (Filed by)
Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
| Form SCHEDULE 13D | |
06/23/2025
5:41 PM | Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Lubner David Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
5:43 PM | Balcom Alexandra (Reporting)
Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
5:46 PM | Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Violin Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
5:22 PM | Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Moran Susan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
5:23 PM | Balcom Alexandra (Reporting)
Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
5:23 PM | Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Violin Jonathan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
5:24 PM | Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Lubner David Charles (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
5:25 PM | Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for CBIO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Crescent Biopharma and its competitors with MarketBeat's FREE daily newsletter. |
06/23/2025
5:26 PM | Brumm Joshua T (Reporting)
Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
5:27 PM | Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
McNeill Jonathan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
5:28 PM | Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Scalzo Richard William (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
5:29 PM | Doughty Christopher Grant (Reporting)
Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
5:29 PM | Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Lynch Ryan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/23/2025
3:30 PM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SCHEDULE 13G | |
06/18/2025
4:28 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2025
5:53 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
7:30 AM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2025
7:30 AM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2025
7:30 AM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
| Form 425 | |
05/29/2025
7:30 AM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
| Form 425 | |
05/14/2025
11:15 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form EFFECT | |
05/14/2025
4:06 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2025
3:39 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 424B3 | |
05/12/2025
6:12 AM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form S-4/A | |
04/28/2025
7:00 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2025
7:01 PM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
| Form 425 | |
04/28/2025
7:17 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form S-4/A | |
04/28/2025
7:00 AM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
| Form 425 | |
04/04/2025
12:29 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form S-4/A | |
04/03/2025
6:30 AM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
| Form 425 | |
04/03/2025
6:30 AM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
| Form 425 | |
02/28/2025
4:05 PM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
| Form 425 | |
02/27/2025
5:01 AM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
| Form 425 | |
02/14/2025
5:38 PM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
01/31/2025
4:00 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
8:00 AM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
8:00 AM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form DEFA14A | |
12/26/2024
3:30 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
This Signal Only Flashes Once Every 4 Years – And It Just Triggered (Ad) This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto.
Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave. Missed the Last Crypto Boom? Don’t Miss This One - PLUS Claim your $10 in Bitcoin |
11/27/2024
1:22 PM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
Logos Global Management LP (Filed by)
| Form SC 13G | |
11/13/2024
3:30 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
3:42 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
3:47 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form DEFA14A | |
11/06/2024
4:41 PM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
11/04/2024
1:01 PM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
Weinstein Benjamin (Filed by)
| Form SCHEDULE 13G/A | |
10/29/2024
7:09 AM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
7:09 AM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form DEFA14A | |
08/15/2024
4:01 PM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
Invus Global Management, LLC (Filed by)
| Form SC 13G/A | |
08/09/2024
3:30 PM | DEBBANE RAYMOND (Reporting)
Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Invus Global Management, LLC (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Siren, L.L.C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
3:30 PM | DEBBANE RAYMOND (Reporting)
Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Invus Global Management, LLC (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Siren, L.L.C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
4:16 PM | DEBBANE RAYMOND (Reporting)
Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Invus Global Management, LLC (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Siren, L.L.C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
2:55 PM | Crescent Biopharma (Filer)
GLYCOMIMETICS INC (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2024
6:24 PM | Crescent Biopharma (Subject)
GLYCOMIMETICS INC (Subject)
Invus Global Management, LLC (Filed by)
| Form SC 13G/A | |
07/29/2024
4:55 PM | DEBBANE RAYMOND (Reporting)
Crescent Biopharma (Issuer)
GLYCOMIMETICS INC (Issuer)
Invus Global Management, LLC (Reporting)
Siren, L.L.C. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
